Investment Analysts’ Updated EPS Estimates for June 29th (ALKS, AMPH, ASML, BHVN, CER, CNMD, CREO, DH, DOCS, DUOL)

Investment Analysts’ updated eps estimates for Monday, June 29th:

Alkermes (NASDAQ:ALKS) had its underperform rating reaffirmed by analysts at Bank of America Corporation.

Amphastar Pharmaceuticals (NASDAQ:AMPH) had its underperform rating reaffirmed by analysts at Bank of America Corporation. The firm currently has a $20.00 target price on the stock, down from their previous target price of $25.00.

ASML (NASDAQ:ASML) had its buy rating reaffirmed by analysts at Barclays PLC.

Biohaven (NYSE:BHVN) had its underperform rating reaffirmed by analysts at Bank of America Corporation. The firm currently has a $11.00 price target on the stock, down from their previous price target of $12.00.

Cerillion (LON:CER) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 2,060 price target on the stock.

CONMED (NYSE:CNMD) had its underperform rating reiterated by analysts at Bank of America Corporation. Bank of America Corporation currently has a $40.00 target price on the stock.

Creo Medical Group (LON:CREO) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd. The firm currently has a GBX 40 price target on the stock.

Definitive Healthcare (NASDAQ:DH) had its underperform rating reaffirmed by analysts at Bank of America Corporation. They currently have a $0.70 price target on the stock.

Doximity (NYSE:DOCS) had its underperform rating reissued by analysts at Bank of America Corporation. The firm currently has a $20.00 target price on the stock, down from their previous target price of $38.00.

Duolingo (NASDAQ:DUOL) had its neutral rating reaffirmed by analysts at DA Davidson. The firm currently has a $120.00 price target on the stock.

Foresight Group (LON:FSG) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 560 target price on the stock.

ForViva (LON:FVA) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 190 target price on the stock.

Holley (NYSE:HLLY) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a $7.00 price target on the stock.

Invinity Energy Systems (LON:IES) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 50 price target on the stock.

Integra Resources (NYSEAMERICAN:ITRG) had its buy rating reissued by analysts at Roth Mkm. Roth Mkm currently has a $6.00 target price on the stock.

Kelly Services (NASDAQ:KELYA) had its outperform rating reissued by analysts at Barrington Research.

Knights Group (LON:KGH) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 355 price target on the stock.

Lantheus (NASDAQ:LNTH) had its market outperform rating reissued by analysts at Citizens Jmp. The firm currently has a $115.00 target price on the stock.

Liquidia (NASDAQ:LQDA) had its neutral rating reiterated by analysts at Bank of America Corporation. Bank of America Corporation currently has a $79.00 price target on the stock, up from their previous price target of $64.00.

Monopar Therapeutics (NASDAQ:MNPR) had its buy rating reissued by analysts at HC Wainwright. They currently have a $105.00 price target on the stock.

Madison Square Garden Entertainment (NYSE:MSGE) had its neutral rating reiterated by analysts at Seaport Research Partners.

ServiceNow (NYSE:NOW) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $150.00 price target on the stock.

NVIDIA (NASDAQ:NVDA) had its buy rating reissued by analysts at Sanford C. Bernstein.

Portmeirion Group (LON:PMP) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Rose Petroleum plc (ROSE.L) (LON:ROSE) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 450 target price on the stock.

Savannah Resources (LON:SAV) had its speculative buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 13 target price on the stock.

Seadrill (NYSE:SDRL) had its buy rating reissued by analysts at BWS Financial. They currently have a $80.00 target price on the stock.

Shake Shack (NYSE:SHAK) had its buy rating reissued by analysts at DA Davidson. The firm currently has a $70.00 price target on the stock.

Sylvania Platinum (LON:SLP) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 174 target price on the stock.

Smith & Nephew (LON:SN) had its sector perform rating reissued by analysts at Royal Bank Of Canada. They currently have a GBX 1,350 price target on the stock.

Smiths News (LON:SNWS) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 85 target price on the stock.

Smiths News (LON:SNWS) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 95 price target on the stock.

Safestay (LON:SSTY) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Secure Trust Bank (LON:STB) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Theravance Biopharma (NASDAQ:TBPH) had its hold rating reiterated by analysts at JonesTrading.

Vox Royalty (NASDAQ:VOXR) had its buy rating reissued by analysts at Roth Mkm. Roth Mkm currently has a $8.00 price target on the stock.

Viridian Therapeutics (NASDAQ:VRDN) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $32.00 price target on the stock.

Wynnstay Group (LON:WYN) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Wynnstay Group (LON:WYN) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 500 target price on the stock.